Gut bacteria tweak may boost heart drug power

NCT ID NCT07203846

First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times

Summary

This study looks at whether an antibiotic called rifaximin can help the blood thinner ticagrelor work better in people who have had a heart attack or unstable angina. The idea is that unhealthy gut bacteria might make the drug less effective. The study will involve 50 adults who are already taking ticagrelor and have high platelet reactivity, meaning their blood is still too sticky. Researchers will give them rifaximin and check if their blood thinning improves.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACS - ACUTE CORONARY SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Cardiology Department, Dr. A. Jurasz University Hospital

    Bydgoszcz, Cuiavian-Pomeranian, 85-094, Poland

Conditions

Explore the condition pages connected to this study.